ArchiMed’s $1.2bn private equity deal with Natus Medical was the Medical devices industry’s biggest deal of Q2 2022 as deals worth $12.2bn were announced globally in the quarter, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 32% over the previous quarter and a drop of 69.3% when compared with the last four-quarter average of $39.55bn.

In terms of number of deals, the sector saw a drop of 11.49% with 539 deals in Q2 2022 against the average of 609.00 deals in the last four-quarters.

In value terms, North America led the activity with deals worth $5.39bn.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Medical devices industry deals in Q2 2022: Top deals

The top five Medical devices industry deals accounted for 33.5% of the overall value during Q2 2022.

The combined value of the top five deals stood at $4.07bn, against the overall value of $12.2bn recorded for the quarter.

The top five Medical devices industry deals of Q2 2022 tracked by GlobalData were:

1) ArchiMed $1.2bn private equity deal with Natus Medical

2) The $1bn acquisition of MediFox DAN Group by ResMed

3) EQT IX Fund $797.86m private equity deal with SPT Labtech

4) The $541.63m acquisition of Phenox by Wallaby Medical

5) Fleury $534.27m acquisition deal with Instituto Hermes Pardini